banner2

Getting started
Duloxetine HCl

Duloxetine HCl - China Manufacturers, Suppliers, Factory

Duloxetine HCl, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

H-His-NH2·2HCl CAS 71666-95-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-His-NH2·2HCl CAS 71666-95-0 Assay ≥98.0% (HPLC)
Read More

H-Nva-OtBu·HCl CAS 119483-47-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Nva-OtBu·HCl CAS 119483-47-5 Assay ≥98.0% (HPLC)

L-Leucine p-Nitroanilide Hydrochloride CAS 16010-98-3 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-Leucine p-Nitroanilide Hydrochloride (H-Leu-PNA·HCl) CAS 16010-98-3 Assay ≥98.0% (HPLC)

H-HomoPro-OMe·HCl CAS 18650-39-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-HomoPro-OMe·HCl CAS 18650-39-0 Assay ≥98.0% (HPLC)

H-Lys(Z)-OtBu·HCl CAS 5978-22-3 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Lys(Z)-OtBu·HCl CAS 5978-22-3 Assay ≥98.0% (HPLC)

H-Ile-NH2·HCl CAS 10466-56-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Ile-NH2·HCl CAS 10466-56-5 Assay ≥98.0% (HPLC)

H-Glu(OMe)-OtBu·HCl CAS 34582-33-7 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — H-Glu(OMe)-OtBu·HCl CAS 34582-33-7 Purity ≥98.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...

2022.11.01 14:36:04
2022.05.17 18:25:46
2022.02.02 15:14:37
2022.01.06 22:53:04
2021.11.03 18:35:01
2021.10.23 19:16:20

related search